Common use of Use of Nycomed Product Clause in Contracts

Use of Nycomed Product. POZEN will provide Nycomed with advance written notice of any clinical trials that POZEN intends to perform during the pre-clinical and clinical development of POZEN Products to the extent that such trials would require the use or testing of Nycomed Products. POZEN will accompany each such notice with clinical trial protocols for the relevant studies. POZEN, at its sole discretion, may redact the protocols submitted to Nycomed to avoid disclosure of the identity of the specific POZEN Product to which such studies relate. POZEN will not initiate any clinical trial for which it has submitted protocols to Nycomed under this Section 5.7 prior to receipt of Nycomed’s approval; provided, however, that such approval will not be unreasonably withheld or delayed, and Nycomed’s failure to respond to such protocols within ********* of receipt thereof shall be deemed to constitute Nycomed’s approval of such protocols.

Appears in 3 contracts

Samples: Development, Option and License Agreement, Development, Option and License Agreement (Pozen Inc /Nc), Development, Option and License Agreement (Pozen Inc /Nc)

AutoNDA by SimpleDocs

Use of Nycomed Product. POZEN will provide Nycomed with advance written notice of any clinical trials that POZEN intends to perform during the pre-clinical and clinical development of POZEN Products Initial Development Program to the extent that such trials would require the use or testing of Nycomed Products. POZEN will accompany each such notice with clinical trial protocols for the relevant studies. POZEN, at its sole discretion, may redact the protocols submitted to Nycomed to avoid disclosure of the identity of the specific POZEN Product to which such studies relate. POZEN will not initiate any clinical trial for which it has submitted protocols to Nycomed under this Section 5.7 2.5 prior to receipt of Nycomed’s approval; provided, however, that such approval will not be unreasonably withheld or delayeddelayed for more than 2 weeks following receipt of such protocols by Nycomed, and Nycomed’s failure to respond to such protocols within ********* 2 weeks of receipt thereof shall be deemed to constitute Nycomed’s approval of such protocols.

Appears in 3 contracts

Samples: Development, Option and License Agreement, Development, Option and License Agreement (Pozen Inc /Nc), Development, Option and License Agreement (Pozen Inc /Nc)

AutoNDA by SimpleDocs
Time is Money Join Law Insider Premium to draft better contracts faster.